Giroctocogene fitelparvovec API Manufacturers
compare suppliers & get competitive offers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Giroctocogene fitelparvovec is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Giroctocogene fitelparvovec or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Giroctocogene fitelparvovec API 2166101-71-7?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Giroctocogene fitelparvovec. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Giroctocogene fitelparvovec
- Synonyms:
- Aav2/6-b-domain-deleted blood coagulation factor viii , Dna (recombinant adeno-associated virus 6 vector pf-07055480 human b-domain-deleted blood-coagulation factor viii-specifying) , PF 07055480 , PF07055480
- Cas Number:
- 2166101-71-7
- DrugBank number:
- DB16174
- Unique Ingredient Identifier:
- C43ZSD4HNV
General Description:
Giroctocogene fitelparvovec, identified by CAS number 2166101-71-7, is a notable compound with significant therapeutic applications. Giroctocogene fitelparvovec is under investigation in clinical trial NCT04370054 (Study to Evaluate the Efficacy and Safety of PF-07055480 in Moderately Severe to Severe Hemophilia a Adults).
Categories:
Giroctocogene fitelparvovec is categorized under the following therapeutic classes: Adeno-associated Viral Vector Therapies. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
